Natalizumab treatment of multiple sclerosis - a Danish nationwide study with 13 years of follow-up.
Mult Scler Relat Disord
; 74: 104713, 2023 Jun.
Article
in En
| MEDLINE
| ID: mdl-37058764
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Multiple Sclerosis, Relapsing-Remitting
/
Multiple Sclerosis
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Mult Scler Relat Disord
Year:
2023
Document type:
Article
Country of publication:
Países Bajos